ID
45491
Description
Principal Investigator: Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA MeSH: Solitary Fibrous Tumors https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568 Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and normal pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA) project.
Link
Keywords
Versions (2)
- 10/31/22 10/31/22 - Simon Heim
- 12/13/22 12/13/22 - Kristina Keller
Copyright Holder
Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA
Uploaded on
December 13, 2022
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000568 Genomic Sequencing of Solitary Fibrous Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
C1266119 (UMLS CUI [1,2])
C5395609 (UMLS CUI [1,3])